Cytori Therapeutics, Inc. was established in 1996 and headquartered in San Diego, California, USA. The Company was founded with a commitment to improve the quality of patients' lives and provide physicians around the world with innovative, regenerative medicine-based products that address unmet medical needs.

In cooperation with its partners, Cytori develops, manufactures, and globally markets medical devices that use unique adult stem cell processing methods, ground-breaking research, and novel clinical therapy approaches - enabling the practice of regenerative medicine in ways that would not otherwise be possible.

Cytori’s cell-based technology provides fast, easy, point-of-care access to a clinical grade mixture of stem and regenerative cells from adipose tissue.

The Cytori platform automates and standardizes the extraction and concentration of a patient’s own adipose derived regenerative cells (ADRCs) for use at the point of care or for future clinical or research use.  Cytori’s technology is broadly applicable for a wide range of diseases.

Video demonstration of Cytori Puregraft:

 


For more information, visit www.cytori.com / www.cellenrich.eu / www.cellreconstruct.eu

Presentation brochure:  Cytori Puregraft